A recent CNN article discussed the latest in the ongoing saga of opioids in the United States. A trial involving three major opioid distributors began last week in West Virginia, claiming they created a public nuisance by failing to monitor, divert or report suspicious orders under the Controlled Substances Act. The three co-defendants are McKesson Corporation, AmerisourceBergen, and Cardinal Health. Between 2006 and 2014, they distributed more than 57 million doses of hydrocodone and oxycodone to a community of roughly 100,000 people.
Three Companies Taken to Court for Opioid Crisis
The outcome of the trial will set the tone for future litigation in opioid-related cases.
May 12, 2021
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now